A detailed history of Pathstone Holdings, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 4,118 shares of UTHR stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,118
Previous 3,955 4.12%
Holding current value
$1.53 Million
Previous $1.26 Million 17.16%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$311.04 - $363.55 $50,699 - $59,258
163 Added 4.12%
4,118 $1.48 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $74,869 - $104,645
328 Added 9.04%
3,955 $1.26 Million
Q1 2024

May 13, 2024

BUY
$210.76 - $249.51 $81,985 - $97,059
389 Added 12.01%
3,627 $833,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $695,781 - $831,971
3,238 New
3,238 $712,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.